- Home
- PHUN vs IMRX Comparison
PHUN vs IMRX Comparison
Compare PHUN & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHUN
- IMRX
- Stock Information
- Founded
- PHUN 2009
- IMRX 2008
- Country
- PHUN United States
- IMRX United States
- Employees
- PHUN N/A
- IMRX N/A
- Industry
- PHUN EDP Services
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- PHUN Technology
- IMRX Health Care
- Exchange
- PHUN Nasdaq
- IMRX Nasdaq
- Market Cap
- PHUN 89.7M
- IMRX 73.2M
- IPO Year
- PHUN N/A
- IMRX 2021
- Fundamental
- Price
- PHUN $4.34
- IMRX $1.72
- Analyst Decision
- PHUN Strong Buy
- IMRX Buy
- Analyst Count
- PHUN 3
- IMRX 7
- Target Price
- PHUN $13.00
- IMRX $12.80
- AVG Volume (30 Days)
- PHUN 1.5M
- IMRX 801.9K
- Earning Date
- PHUN 11-07-2024
- IMRX 11-13-2024
- Dividend Yield
- PHUN N/A
- IMRX N/A
- EPS Growth
- PHUN N/A
- IMRX N/A
- EPS
- PHUN N/A
- IMRX N/A
- Revenue
- PHUN $3,537,000.00
- IMRX N/A
- Revenue This Year
- PHUN N/A
- IMRX N/A
- Revenue Next Year
- PHUN $93.33
- IMRX N/A
- P/E Ratio
- PHUN N/A
- IMRX N/A
- Revenue Growth
- PHUN N/A
- IMRX N/A
- 52 Week Low
- PHUN $2.85
- IMRX $1.00
- 52 Week High
- PHUN $24.50
- IMRX $8.07
- Technical
- Relative Strength Index (RSI)
- PHUN 43.55
- IMRX 37.40
- Support Level
- PHUN $4.17
- IMRX $1.52
- Resistance Level
- PHUN $4.78
- IMRX $1.93
- Average True Range (ATR)
- PHUN 0.28
- IMRX 0.19
- MACD
- PHUN 0.05
- IMRX -0.05
- Stochastic Oscillator
- PHUN 25.01
- IMRX 21.95
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.